NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
25 hedge funds and large institutions have $5.07M invested in NKGen Biotech, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.83M | |
| 2 | +$1.24M | |
| 3 | +$151K | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$95.5K |
| 5 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
+$57K |
Top Sellers
| 1 | -$36.1K | |
| 2 | -$9.1K | |
| 3 | -$5.86K | |
| 4 |
TCM
Towneley Capital Management
Laguna Hills,
California
|
-$3.78K |
| 5 |
HF
HRT Financial
New York
|
-$3K |